Uterine serous and clear cell carcinomas: Hormonal profile and expression of steroid hormone receptors in mitochondria.

A Anna Petrovna Menshenina (National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation) E Elena M. Frantsiyants (National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation) V Valeria Bandovkina (National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation) T Tatiana I. Moiseenko (National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation) M Mark A. Rogozin (National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation) E Ekaterina I. Surikova (National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation) I Irina Valerevna Neskubina (National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation) A Alla A. Adamyan (National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation) O Oksana E. Kravtsova (National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation) O Olga Selezneva (National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation) E Elena A. Ozerkova (National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation) E Elena V. Shalashnaya (National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation) S Sofya A. Kornienko (Rostov State Medical University, Rostov-on-Don, Russian Federation) E Ekaterina V. Verenikina (National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation) Z Zlata V. Verenikina (Rostov State Medical University, Rostov-on-Don, Russian Federation) L Larisa N. Vashchenko (National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation) I Iuliana S. Shatova (National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation) A Anna Yurevna Ardzha (National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation) A Arthur Andryasovich Antonyan (National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation) O Oleg Ivanovich Kit (National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation)

Abstract

e17624 Background: Uterine serous carcinoma (USC) and clear cell carcinoma (CCC) are rare but aggressive histological subtypes of endometrial cancer associated with a poor prognosis. Beyond their classical role in energy metabolism, mitochondria are involved in cell signaling. Steroid hormone receptors are localized within mitochondria, allowing estrogens, progesterone, and androgens to directly influence mitochondrial function, thereby regulating apoptosis and energy metabolism. The aim of this study was a comparative assessment of steroid hormone levels and their receptor expression in mitochondria isolated from USC and CCC tissues versus mitochondria from intact endometrium. Methods: Mitochondria were isolated from tumor tissues of 41 patients with rare forms of endometrial cancer: USC (n=21) and CCC (n=20). All patients presented with stage III–IV, high-grade (G3) disease; the mean age was 59.6±6.7 years. Mitochondria from histologically normal (intact) endometrium (n=20) obtained from women undergoing surgery for uterine fibroids (mean age 57.8±8.2 years) served as controls. Concentrations of estrone (E1), estradiol (E2), estriol (E3), testosterone (T), progesterone (P4), and receptors (ERα, ERβ, AR, PR) were determined in the purified mitochondrial fraction using enzyme-linked immunosorbent assay (ELISA). Statistical analysis was performed using parametric and nonparametric tests with adjustments for multiple comparisons. Results: In USC and CCC mitochondria, a statistically significant (p < 0.05) increase was observed compared to the control group for: E2 (1.3- to 2-fold), E3 (1.8- to 2.2-fold), P4 and T (1.5-fold on average), ERβ (more than 2-fold), and PR (3.4- to 5.2-fold). However, ERα and AR levels were significantly increased only in USC (1.8-fold, p < 0.05 and 2.2-fold, p < 0.05, respectively), whereas no significant differences were found in CCC mitochondria. Conclusions: The findings demonstrate significant alterations in the mitochondrial hormonal and receptor profiles in serous and clear cell endometrial carcinomas. Overexpression of ERβ and PR, alongside the accumulation of steroid hormones, indicates the activation of mitochondrial hormonal signaling pathways. The observed differences suggest distinct mechanisms of hormonal regulation: estrogen- and androgen-dependent signaling predominates in USC, while progesterone-dependent signaling predominates in CCC. These features may determine differences in the biological behavior of these tumors and their response to therapy.

Article Details

Volume / Issue Vol. 44, Issue 16_suppl
Published June 01, 2026
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (20)

A

Anna Petrovna Menshenina

National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation

E

Elena M. Frantsiyants

National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation

V

Valeria Bandovkina

National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation

T

Tatiana I. Moiseenko

National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation

M

Mark A. Rogozin

National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation

E

Ekaterina I. Surikova

National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation

I

Irina Valerevna Neskubina

National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation

A

Alla A. Adamyan

National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation

O

Oksana E. Kravtsova

National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation

O

Olga Selezneva

National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation

E

Elena A. Ozerkova

National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation

E

Elena V. Shalashnaya

National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation

S

Sofya A. Kornienko

Rostov State Medical University, Rostov-on-Don, Russian Federation

E

Ekaterina V. Verenikina

National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation

Z

Zlata V. Verenikina

Rostov State Medical University, Rostov-on-Don, Russian Federation

L

Larisa N. Vashchenko

National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation

I

Iuliana S. Shatova

National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation

A

Anna Yurevna Ardzha

National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation

A

Arthur Andryasovich Antonyan

National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation

O

Oleg Ivanovich Kit

National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation